key: cord-0841633-n9ym92bv
authors: Yesilkaya, Umit Haluk; Balcioglu, Yasin Hasan; Sahin, Serhat
title: Reissuing the sigma receptors for SARS-CoV-2
date: 2020-08-11
journal: J Clin Neurosci
DOI: 10.1016/j.jocn.2020.08.014
sha: 1d79f6115300af8bd4d7689adb2bd79ea2995848
doc_id: 841633
cord_uid: n9ym92bv

• Receptor binding is a major determinant of tissue tropism for SARS-CoV-2. • Neurotropism of SARS-CoV-2 associated with a broad range of receptors in the central nervous system (CNS). • Sigma receptors may be involved in the neuronal transmission of SARS-CoV-2.

Receptor binding is one of the major determinants of tissue tropism for coronaviruses and seems an important mediator of the pathophysiology of COVID-19. With this regard, the emerging review article These functions of σ1 have also been postulated to take part in the mediation of the early stages of viral RNA replication. Previous research has suggested that pharmacological manipulation of both σ1 and σ2 activity might provide antiviral activity, particularly for RNA viruses including hepatitis C virus (HCV) and human immunodeficiency viruses (HIV). Functional deficiency and reduced expression of σ1 might be associated with decreased intracellular titration of HCV-RNA [5] , while a pharmacological selective σ1 antagonist BD1047 has been shown to alter the stimulating effect of cocaine on the intracellular HIV-1 expression in microglia [6] . These findings indicate that σ receptors may also be involved in the neuronal transmission of SARS-CoV-2, which has a genome structure similar to those of HCV and HIV. Clinical observations that many patients with COVID-19 present with anosmia may empirically support our argument as SARS-CoV-2 might have an affinity to olfactor bulb which is enriched in σ receptors. Another important implication of σ receptor involvement in the SARS-CoV-2 infection may lie in the argument that numerous psychotropics likes of haloperidol, fluvoxamine, fluphenazine and chlorpromazine considerably interacts with σ receptors, which may highlight the potential clinical utility of such agents in the management of SARS-CoV-2 infection. Nevertheless, such an argument needs decent support from wellestablished clinical research. Although abovementioned postulations galvanize our interest in the comprehension of the pathophysiology of CNS involvement of SARS-CoV-2, we disclose that much more work is required to illuminate and guide the specific underpinnings of SARS-CoV-2's brain involvement.

How SARS-Cov-2 can involve the central nervous system. A systematic analysis of literature of the department of human neurosciences of sapienza university, italy

May the Central Nervous System Be Fogged by the Cytokine Storm in COVID-19?: an

Neuroimmune correlates of the nervous system involvement of COVID-19: A commentary

A SARS-CoV-2 protein interaction map reveals targets for drug repurposing

Sigma-1 Receptor Regulates Early Steps of Viral RNA Replication at the Onset of Hepatitis C Virus Infection

Cocaine-induced HIV-1 expression in microglia involves sigma-1 receptors and transforming growth factor-β1

 Receptor binding is a major determinant of tissue tropism for SARS

 Neurotropism of SARS-CoV-2 associated with a broad range of receptors in the central nervous system (CNS)

Sigma receptors may be involved in the neuronal transmission of SARS-CoV-2